Clinical Outcomes of Escalation vs Early Intensive Disease-Modifying Therapy in Patients With Multiple Sclerosis

IMPORTANCE: Uncertainty remains about how aggressively to treat early multiple sclerosis. High-efficacy disease-modifying therapies (DMTs) are often reserved for individuals expressing poor prognostic features at baseline. OBJECTIVE: To analyze long-term outcomes in a population-based cohort accordi...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:JAMA Neurol
Main Authors: Harding, Katharine, Williams, Owain, Willis, Mark, Hrastelj, James, Rimmer, Anthony, Joseph, Fady, Tomassini, Valentina, Wardle, Mark, Pickersgill, Trevor, Robertson, Neil, Tallantyre, Emma
Formato: Artigo
Idioma:Inglês
Publicado em: American Medical Association 2019
Assuntos:
Original Investigation
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6515582/
https://ncbi.nlm.nih.gov/pubmed/30776055
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1001/jamaneurol.2018.4905
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados